Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Malignant hypertension
ADR ID BADD_A02649
ADR Hierarchy
24      Vascular disorders
24.08      Vascular hypertensive disorders
24.08.01      Accelerated and malignant hypertension
24.08.01.002      Malignant hypertension
Description A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction. [MeSH]
MedDRA Code 10025600
MeSH ID D006974
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Essential hypertension, malignant | Hypertension malignant | Malignant essential hypertension | Malignant hypertension | Malignant hypertension NOS | Malignant secondary hypertension | Malignant secondary hypertension NOS | Other malignant secondary hypertension | Secondary hypertension, malignant | Hypertension, Malignant | Malignant Hypertension
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000303%
BADD_D00178Atenolol0.000074%
BADD_D00330Cabozantinib--
BADD_D00611Desflurane--
BADD_D00886Ferrosoferric oxide--
BADD_D01009Gemcitabine0.001066%
BADD_D01252Leflunomide0.002066%
BADD_D01475Mirabegron0.000828%
BADD_D01566Nifedipine--
BADD_D01687Pazopanib0.000533%
BADD_D01888Quetiapine0.001910%
BADD_D02016Sibutramine--
BADD_D02100Sunitinib0.001332%
BADD_D02165Teriflunomide0.001737%
BADD_D02334Vandetanib--
BADD_D02419Rosiglitazone0.000801%
BADD_D02466Levomilnacipran0.000290%
The 1th Page    1    Total 1 Pages